CA
BBNX icon

Clearstead Advisors’s Beta Bionics BBNX Stock Holding History

Clearstead Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204 Buy
+13
New +$155 ﹤0.01% 3197
2025
Q3 		– Sell
-90
Closed -$1.31K – 3286
2025
Q2 		$1.31K Hold
90
– – ﹤0.01% 2398
2025
Q1 		$1.1K Buy
+90
New +$1.68K ﹤0.01% 1978

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Clearstead Advisors's BBNX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Beta Bionics (BBNX) in Q2 2026: 13 shares worth $204. The stake represents ﹤0.01% of the portfolio and ranks #3197 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in BBNX as recently as Q2 2025.

Clearstead Advisors first reported a position in BBNX in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.31K in Q2 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Clearstead Advisors held 13 shares of Beta Bionics worth $204 as of Q2 2026.
  • Beta Bionics was a new Clearstead Advisors position in Q2 2026.
  • Beta Bionics made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3197 holding.
  • Clearstead Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 3 quarters since.
  • Clearstead Advisors's Beta Bionics position peaked at $1.31K in Q2 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.